000 01214 a2200337 4500
005 20250514050316.0
264 0 _c20021108
008 200211s 0 0 eng d
022 _a1537-6591
024 7 _a10.1086/342325
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaly, P
245 0 0 _aReply to Dr. Charlebois et Al. (Clin infect dis 2002; 34:425-33).
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cNov 2002
300 _a1135 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aCanada
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLife Expectancy
650 0 4 _aMale
650 0 4 _aMethicillin Resistance
650 0 4 _aPrevalence
650 0 4 _aSerotyping
650 0 4 _aStaphylococcal Infections
_xepidemiology
650 0 4 _aStaphylococcus aureus
_xdrug effects
700 1 _aBryce, E A
700 1 _aBuxton, J
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 35
_gno. 9
_gp. 1135
856 4 0 _uhttps://doi.org/10.1086/342325
_zAvailable from publisher's website
999 _c12194083
_d12194083